Author:
Au Yeung Victor,Thapa Kiran,Rawlinson William,Georgiou Andrew,Post Jeffrey J.,Overton Kristen
Abstract
Abstract
Background
Influenza is a highly contagious respiratory virus with clinical impacts on patient morbidity, mortality and hospital bed management. The effect of rapid nucleic acid testing (RPCR) in comparison to standard multiplex PCR (MPCR) diagnosis in treatment decisions is unclear. This study aimed to determine whether RPCR influenza testing in comparison to standard MPCR testing was associated with differences in antibiotic and antiviral (oseltamivir) utilisation and hospital length of stay in emergency department and inpatient hospital settings.
Methods
A retrospective cohort study of positive influenza RPCR and MPCR patients was performed utilising data from the 2017 influenza season. Medical records of correlating patient presentations were reviewed for data collection. An analysis of RPCR versus MPCR patient outcomes was performed examining test turnaround time, antibiotic initiation, oseltamivir initiation and hospital length of stay for both emergency department and inpatient hospital stay. Subgroup analysis was performed to assess oseltamivir use in high risk populations for influenza complications. Statistical significance was assessed using Mann-Whitney test for numerical data and Chi-squared test for categorical data. Odds ratio with 95% confidence intervals were calculated where appropriate.
Results
Overall, 122 RPCR and 362 MPCR positive influenza patients were included in this study. Commencement of antibiotics was less frequent in the RPCR than MPCR cohorts (51% vs 67%; p < 0.01, OR 0.52; 95% CI 0.34–0.79). People at high risk of complications from influenza who were tested with the RPCR were more likely to be treated with oseltamivir compared to those tested with the MPCR (76% vs 63%; p = 0.03, OR 1.81; 95% CI 1.07–3.08). Hospital length of stay was not impacted when either test was used in the emergency department and inpatient settings.
Conclusions
These findings suggest utilisation of RPCR testing in influenza management can improve antibiotic stewardship through reduction in antibiotic use and improvement in oseltamivir initiation in those at higher risk of complications. Further research is required to determine other factors that may have influenced hospital length of stay and a cost-benefit analysis should be undertaken to determine the financial impact of the RPCR test.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Australian Bureau of Statistics. 3303.0 - Causes of Death, Australia, 2017. Deaths due to Influenza 2017. 2018. https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by Subject/3303.0~2017~Main Features~Deaths due to influenza~5. Accessed 14 Apr 2019.
2. eTG Complete. Influenza. In: eTG Complete [digital]. June 2019. Melbourne VIC: Therapeutic Guidelines Limited; 2019. https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?topicfile=influenza&guidelineName=Antibiotic#toc_d1e63. Accessed 14 Apr 2019.
3. Australian Government Department of Health. 2017 Influenza Season in Australia 2017. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm/$File/2017-season-summary-22112017.pdf. Accessed 15 Apr 2019.
4. Troeger CE, Blacker BF, Khalil IA, Zimsen SRM, Albertson SB, Abate D, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of disease study 2017. Lancet Respir Med. 2019;7:69–89. https://doi.org/10.1016/S2213-2600(18)30496-X.
5. Varghese BM, Dent E, Chilver M, Cameron S, Stocks NP. Epidemiology of viral respiratory infections in Australian working-age adults (20–64 years): 2010–2013. Epidemiol Infect. 2018;146(5):619–26. https://doi.org/10.1017/S0950268818000286.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献